Literature DB >> 23420233

Definition of a positive test result in computed tomography screening for lung cancer: a cohort study.

Claudia I Henschke1, Rowena Yip, David F Yankelevitz, James P Smith.   

Abstract

BACKGROUND: Low-dose computed tomography screening for lung cancer can reduce mortality among high-risk persons, but "false-positive" findings may result in unnecessary evaluations with attendant risks. The effect of alternative thresholds for defining a positive result on the rates of positive results and cancer diagnoses is unknown.
OBJECTIVE: To assess the frequency of positive results and potential delays in diagnosis in the baseline round of screening by using more restrictive thresholds.
DESIGN: Prospective cohort study.
SETTING: Multi-institutional International Early Lung Cancer Action Program. PATIENTS: 21 136 participants with baseline computed tomography performed between 2006 and 2010. MEASUREMENTS: The frequency of solid and part-solid pulmonary nodules and the rate of lung cancer diagnosis by using current (5 mm) and more restrictive thresholds of nodule diameter.
RESULTS: The frequency of positive results in the baseline round by using the current definition of positive result (any parenchymal, solid or part-solid, noncalcified nodule ≥5.0 mm) was 16% (3396/21 136). When alternative threshold values of 6.0, 7.0, 8.0 and 9.0 mm were used, the frequencies of positive results were 10.2% (95% CI, 9.8% to 10.6%), 7.1% (CI, 6.7% to 7.4%), 5.1% (CI, 4.8% to 5.4%), and 4.0% (CI, 3.7% to 4.2%), respectively. Use of these alternative definitions would have reduced the work-up by 36%, 56%, 68%, and 75%, respectively. Concomitantly, lung cancer diagnostics would have been delayed by at most 9 months for 0%, 5.0% (CI, 1.1% to 9.0%), 5.9% (CI, 1.7 to 10.1%), and 6.7% (CI, 2.2% to 11.2%) of the cases of cancer, respectively. LIMITATION: This was a retrospective analysis and thus whether delays in diagnosis would have altered outcomes cannot be determined.
CONCLUSION: These findings suggest that using a threshold of 7 or 8 mm to define positive results in the baseline round of computed tomography screening for lung cancer should be prospectively evaluated to determine whether the benefits of decreasing further work-up outweigh the consequent delay in diagnosis in some patients.

Entities:  

Mesh:

Year:  2013        PMID: 23420233     DOI: 10.7326/0003-4819-158-4-201302190-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  58 in total

1.  Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.

Authors:  Paul F Pinsky; David S Gierada; William Black; Reginald Munden; Hrudaya Nath; Denise Aberle; Ella Kazerooni
Journal:  Ann Intern Med       Date:  2015-04-07       Impact factor: 25.391

Review 2.  Screening for lung cancer with low-dose computed tomography: a review of current status.

Authors:  Henry M Marshall; Rayleen V Bowman; Ian A Yang; Kwun M Fong; Christine D Berg
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

3.  Probability of lung cancer based on the size threshold and volume-doubling time for lung nodules detected in low-dose CT screening.

Authors:  Hyun Lee; Sang-Won Um
Journal:  Ann Transl Med       Date:  2015-02

4.  Implementing computed tomography-based lung cancer screening in the community.

Authors:  James L Mulshine; Laurie Fenton Ambrose
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 5.  The Pursuit of Noninvasive Diagnosis of Lung Cancer.

Authors:  Thomas Atwater; Christine M Cook; Pierre P Massion
Journal:  Semin Respir Crit Care Med       Date:  2016-10-12       Impact factor: 3.119

Review 6.  Implementing lung cancer screening in the real world: opportunity, challenges and solutions.

Authors:  Robert J Optican; Caroline Chiles
Journal:  Transl Lung Cancer Res       Date:  2015-08

7.  Effect of an Automated Tracking Registry on the Rate of Tracking Failure in Incidental Pulmonary Nodules.

Authors:  Jonathan Shelver; Chris H Wendt; Melissa McClure; Brian Bell; Angela E Fabbrini; Thomas Rector; Kathryn Rice
Journal:  J Am Coll Radiol       Date:  2017-04-21       Impact factor: 5.532

Review 8.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

Review 9.  The importance of the regimen of screening in maximizing the benefit and minimizing the harms.

Authors:  Claudia I Henschke; Kunwei Li; Rowena Yip; Mary Salvatore; David F Yankelevitz
Journal:  Ann Transl Med       Date:  2016-04

10.  Assessing the benefits and harms of low-dose computed tomography screening for lung cancer.

Authors:  Paul F Pinsky
Journal:  Lung Cancer Manag       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.